Exercise testing can be a powerful tool for diagnosing chronic heart and lung conditions and measuring responses to treatment, according to new research published in the European Respiratory Journal.
Contrary to popular wisdom, heart disease is not primarily a male disease, and is in fact statistically far more deadly when it occurs in women. Most women are not aware that heart disease is the number one killer of women, far greater than any other disease.
Even regular use of prenatal multivitamin supplements is not adequate to prevent vitamin D insufficiency, University of Pittsburgh researchers report in the current issue of the Journal of Nutrition, the publication of the American Society for Nutrition.
The UK Alzheimer?s Research Trust has called a report forecasting a huge rise in UK dementia cases a ?clear and stark warning? that the government needs to urgently increase its funding of research into the disease.
“Nanotechnology has the potential to generate enormous health benefits for the more than five billion people living in the developing world,” according to Dr. Peter A. Singer, senior scientist at the McLaughlin-Rotman Centre for Global Health and Professor of Medicine at University of Toronto.
Smoking appears to increase the risk of becoming infected with tuberculosis and the risk for the development of active disease upon infection, according to an analysis of previously published research in the Feb. 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Chemists at the University of Liverpool have designed a unique structure to capture the movement of atoms which may impact on future designs of pharmaceuticals.
The U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta(R) (duloxetine HCl) for the treatment of generalised anxiety disorder (GAD), Eli Lilly and Company (NYSE: LLY) and Boehringer Ingelheim announced today.
Dr. Vafa Shahabi and her research team at Advaxis have designed several new strains of the Listeria bacteria that are programmed to kill off specific cancers.
On Feb. 18, Nature Genetics published the largest-ever study on the genetics of autism. The research is the fruit of an international autism genetics consortium, called the Autism Genome Project.